Sec22b knock-down and Ykt6 overexpression could switch the outcome of rapamycin posttreatment on infarction from deterioration to improvement, suggesting that modest regulation of Sec22b and Ykt6 could extend the therapeutic window of pharmacological autophagy induction for neuroprotection in cerebral ischemia. The gene discussed is YKT6; the disease is infarction.